The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

Squamous cell cancer is a type of skin cancer that affects the middle and outer layers of the skin. It is the most common type of cancer affecting the eye’s conjunctiva. Squamous cell carcinoma ...

Postoperative nivolumab added to standard-of-care adjuvant cisplatin radiotherapy “represents a potential new standard.” ...

The type of eye cancer you have depends on the type of cell the cancer started in. Cancer that starts in the eye is called primary eye cancer. This section is about primary eye cancer. Sometimes ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the ...

These lesions may progress to squamous-cell carcinoma. Panel A shows the total numbers of white cells, polymorphonuclear neutrophils, monocytes, and lymphocytes in the study patient’s blood for ...